JenaValve raises $5m
As first reported by Fink Densford of MassDevice:
JenaValve Technology has raised $4.9 million in a new round of debt financing, according to an SEC filing posted this week.
The Irvine, Calif.-based company is one of several smaller players looking to enter the transcatheter aortic valve implant space as it challenges major players Edwards Lifesciences (NYSE:EW), Medtronic (NYSE:MDT), Abbott (NYSE:ABT) and Boston Scientific (NYSE:BSX).
See full post at MassDevice Here